Pharmaceuticals in the United States of America (USA) - Market Summary, Competitive Analysis and Forecast, 2016-2025

July 2021 | 51 pages | ID: PE3917C84F1EEN
MarketLine

Abstracts

Pharmaceuticals in the United States of America (USA) - Market @Summary, Competitive Analysis and Forecast, 2016-2025

SUMMARY

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The US pharmaceuticals market had total revenues of $387.0bn in 2020, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2020.
• The US government has invested heavily in pharmaceutical companies in 2020 to accelerate the development of vaccines to safeguard its citizens from the coronavirus outbreak. This has aided a return to positive market growth.
• Plans to build on the Affordable Care Act under Joe Biden’s upcoming administration in 2021 could contribute to a slowdown in market growth as healthcare becomes more affordable and accessible, and the ability of pharmaceutical companies to freely set prices is limited.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the United States pharmaceuticals market by value in 2020?
• What will be the size of the United States pharmaceuticals market in 2025?
• What factors are affecting the strength of competition in the United States pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in the United State's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent M&A activity?
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?

8 COMPANY PROFILES

8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United States pharmaceuticals market value: $ billion, 2016-20
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: United States pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: United States pharmaceuticals market share: % share, by value, 2020
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: Merck & Co., Inc.: key facts
Table 17: Merck & Co., Inc.: Annual Financial Ratios
Table 18: Merck & Co., Inc.: Key Employees
Table 19: Merck & Co., Inc.: Key Employees Continued
Table 20: United States size of population (million), 2016-20
Table 21: United States gdp (constant 2005 prices, $ billion), 2016-20
Table 22: United States gdp (current prices, $ billion), 2016-20
Table 23: United States inflation, 2016-20
Table 24: United States consumer price index (absolute), 2016-20
Table 25: United States exchange rate, 2016-20

List Of Figures

LIST OF FIGURES

Figure 1: United States pharmaceuticals market value: $ billion, 2016-20
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2020
Figure 10: United States pharmaceuticals market share: % share, by value, 2020